article thumbnail

STAT+: As pharmaceutical companies bemoan Medicare’s drug negotiations, hospitals and doctors stay mum

STAT

The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.

Hospitals 359
article thumbnail

STAT+: How AI can distort clinical decision-making to prioritize profits over patients

STAT

More than a decade ago, Ken Mandl was on a call with a pharmaceutical company and the leader of a social network for people with diabetes. The drug maker was hoping to use the platform to encourage its members to get a certain lab test.    The test could determine a patient’s need for a helpful drug.

Hospitals 261
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Hospital claims it was ‘drastically’ overcharged by pharma in a federal drug discount program

STAT

For several years , some of the world’s largest pharmaceutical companies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. and their number has grown over the years.

Hospitals 318
article thumbnail

STAT+: Truveta enlists health systems, drugmakers to launch ambitious new genomic database

STAT

The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceutical company Regeneron has invested $119.5

article thumbnail

Long-overlooked scientist shares Lasker Award with other GLP-1 researchers

STAT

Read the rest…

article thumbnail

STAT+: Feds threaten Sanofi with sanctions over plan to change payment terms for a federal drug discount program

STAT

government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceutical company has been threatened with such a step. Continue to STAT+ to read the full story…

Hospitals 267
article thumbnail

STAT+: Novartis sues Maryland over the role of contract pharmacies in a U.S. drug discount program

STAT

Novartis has filed a lawsuit seeking to block a Maryland law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial U.S. government drug discount program. Continue to STAT+ to read the full story…

Hospitals 278